ras-raf interaction inhibitors (NexusPharma)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameras-raf interaction inhibitors (NexusPharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGTPase Ras inhibitorsRAF serine/threonine protein kinase inhibitors
TargetsGTPase RasRAF serine/threonine protein kinase
Therapy Area/IndicationsVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNexus Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNexus Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsVirus Diseases

Other Information

ATC CodeN/A
Related LinksN/A